Pathophysiology of the basal ganglia and movement disorders: From animal models to human clinical applications

Neuroscience and Biobehavioral Reviews

Volumn 32, Issue 3, 2008, Pages 367-377

  Israel, Zvi ^a   Bergman, Hagai ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

DBS; MPTP; Neural network; Parkinson's disease; Primate

Indexed keywords

DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BASAL GANGLION; BRAIN ELECTROPHYSIOLOGY; CELL NUCLEUS; CELL SYNCHRONIZATION; CONTROLLED STUDY; DOPAMINE RELEASE; EARLY DIAGNOSIS; ELECTRODE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MICROELECTRODE; MOTOR DYSFUNCTION; NERVE CELL NETWORK; NONHUMAN; PATHOPHYSIOLOGY; PRIMATE; PRIORITY JOURNAL; REVIEW;

ANIMALS; BASAL GANGLIA; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; HAPLORHINI; HUMANS; MICROELECTRODES; MOVEMENT DISORDERS; MPTP POISONING; RATS;

EID: 38649126183     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2007.08.005     Document Type: Review

References (151)

1. Aizman O., Brismar H., Uhlen P., Zettergren E., Levey A.I., Forssberg H., Greengard P., and Aperia A. Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nature Neuroscience 3 (2000) 226-230
2. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends in Neuroscience 12 (1989) 366-375
3. Alexander G.E., and DeLong M.R. Microstimulation of the primate neostriatum. I. Physiological properties of striatal microexcitable zones. Journal of Neurophysiology 53 (1985) 1401-1416
4. Alexander G.E., and DeLong M.R. Microstimulation of the primate neostriatum. II. Somatotopic organization of striatal microexcitable zones and their relation to neuronal response properties. Journal of Neurophysiology 53 (1985) 1417-1430
5. Anderson M.E., and Horak F.B. Influence of the globus pallidus on arm movements in monkeys. III. Timing of movement-related information. Journal of Neurophysiology 54 (1985) 433-448
6. Aosaki T., Graybiel A.M., and Kimura M. Effect of the nigrostriatal dopamine system on acquired neural responses in the striatum of behaving monkeys. Science 265 (1994) 412-415
7. Aosaki T., Kimura M., and Graybiel A.M. Temporal and spatial characteristics of tonically active neurons of the primate's striatum. Journal of Neurophysiology 73 (1995) 1234-1252
8. Aubert I., Ghorayeb I., Normand E., and Bloch B. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum. The Journal of Comparative Neurology 418 (2000) 22-32
9. Aziz T.Z., Peggs D., Sambrook M.A., and Crossman A.R. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Movement Disorders 6 (1991) 288-293
10. Ballard P.A., Tetrud J.W., and Langston J.W. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP): seven cases. Neurology 35 (1985) 949-956
11. Bankiewicz K.S., Oldfield E.H., Chiueh C.C., Doppman J.L., Jacobowitz D.M., and Kopin I.J. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Science 39 (1986) 7-16
12. Bar-Gad I., and Bergman H. Stepping out of the box: information processing in the neural networks of the basal ganglia. Current Opinion in Neurobiology 11 (2001) 689-695
13. Bar-Gad I., Heimer G., Ritov Y., and Bergman H. Functional correlations between neighboring neurons in the primate globus pallidus are weak or nonexistent. The Journal of Neuroscience 23 (2003) 4012-4016
14. Bar-Gad I., Morris G., and Bergman H. Information processing, dimensionality reduction and reinforcement learning in the basal ganglia. Progress in Neurobiology 71 (2003) 439-473
15. Bar-Gad I., Elias S., Vaadia E., and Bergman H. Complex locking rather than complete cessation of neuronal activity in the globus pallidus of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primate in response to pallidal microstimulation. The Journal of Neuroscience 24 (2004) 9410-9419
16. Baron M.S., Vitek J.L., Bakay R.A., Green J., Kaneoke Y., Hashimoto T., Turner R.S., Woodard J.L., Cole S.A., McDonald W.M., and DeLong M.R. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study [see comments]. Annals of Neurology 40 (1996) 355-366
17. Beiser D.G., Hua S.E., and Houk J.C. Network models of the Basal Ganglia. Current Opinion in Neurobiology 7 (1997) 185-190
18. Benabid A.L. Deep brain stimulation for Parkinson's disease. Current Opinion in Neurobiology 13 (2003) 696-706
19. Benabid A.L., Pollak P., Gross C., Hoffmann D., Benazzouz A., Gao D.M., Laurent A., Gentil M., and Perret J. Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotactic and Functional Neurosurgery 62 (1994) 76-84
20. Benazzouz A., Gross C., Dupont J., and Bioulac B. MPTP induced hemiparkinsonism in monkeys: behavioral, mechanographic, electromyographic and immunohistochemical studies. Experimental Brain Research 90 (1992) 116-120
21. Benazzouz A., Boraud T., Feger J., Burbaud P., Bioulac B., and Gross C. Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates: a comparison with L-Dopa treatment. Movement Disorders 11 (1996) 627-632
22. Benazzouz A., Gao D.M., Ni Z.G., Piallat B., Bouali B.R., and Benabid A.L. Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience 99 (2000) 289-295
23. Bergman H., Wichmann T., and DeLong M.R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249 (1990) 1436-1438
24. Bergman H., Wichmann T., Karmon B., and DeLong M.R. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. Journal of Neurophysiology 72 (1994) 507-520
25. Bezard E., Boraud T., Bioulac B., and Gross C.E. Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms. European Journal of Neuroscience 11 (1999) 2167-2170
26. Bezard E., Dovero S., Prunier C., Ravenscroft P., Chalon S., Guilloteau D., Crossman A.R., Bioulac B., Brotchie J.M., and Gross C.E. Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's Disease. The Journal of Neuroscience 21 (2001) 6853-6861
27. Bolam J.P., Hanley J.J., Booth P.A., and Bevan M.D. Synaptic organisation of the basal ganglia. Journal of Anatomy 196 Part 4 (2000) 527-542
28. Boraud T., Bezard E., Bioulac B., and Gross C. High frequency stimulation of the internal Globus Pallidus (GPi) simultaneously improves parkinsonian symptoms and reduces the firing frequency of GPi neurons in the MPTP-treated monkey. Neuroscience Letters 215 (1996) 17-20
29. Boraud T., Bezard E., Guehl D., Bioulac B., and Gross C. Effects of L-DOPA on neuronal activity of the globus pallidus externalis (Gpe) and globus pallidus internalis (GPi) in the MPTP-treated monkey. Brain Research 787 (1998) 157-160
30. Boraud T., Bezard E., Guehl D., Bioulac B., and Gross C. Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey. Brain Research 787 (1998) 157-160
31. Boraud T., Bezard E., Guehl D., Bioulac B., and Gross C. Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey. Brain Research 787 (1998) 157-160
32. Boraud T., Bezard E., Bioulac B., and Gross C.E. Ratio of inhibited-to-activated pallidal neurons decreases dramatically during passive limb movement in the MPTP-treated monkey. Journal of Neurophysiology 83 (2000) 1760-1763
33. Boraud T., Bezard E., Bioulac B., and Gross C.E. Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey. Brain 124 (2001) 546-557
34. Brown R.G., and Marsden C.D. Cognitive function in Parkinson's disease: from description to theory. Trends in Neurosciences 13 (1990) 21-29
35. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., and Kopin I.J. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proceedings of the National Academy of Sciences of the United States of America 80 (1983) 4546-4550
36. Chiueh C.C., Burns R.S., Markey S.P., Jacobowitz D.M., and Kopin I.J. Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys. Life Science 36 (1985) 213-218
37. DeLong M.R. Activity of pallidal neurons during movement. Journal of Neurophysiology 34 (1971) 414-427
38. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends in Neuroscience 13 (1990) 281-285
39. Diamantaras K.I., and Kung S.Y. Principal Component Neural Networks-Theory and Applications (1996), Wiley, New York
40. Dostrovsky J.O., Levy R., Wu J.P., Hutchison W.D., Tasker R.R., and Lozano A.M. Microstimulation-induced inhibition of neuronal firing in human globus pallidus. Journal of Neurophysiology 84 (2000) 570-574
41. Doudet D., Gross C., Lebrun Grandie P., and Bioulac B. MPTP primate model of Parkinson's disease: a mechanographic and electromyographic study. Brain Research 335 (1985) 194-199
42. Doudet D.J., Gross C., Arluison M., and Bioulac B. Modifications of precentral cortex discharge and EMG activity in monkeys with MPTP-induced lesions of DA nigral neurons. Experimental Brain Research 80 (1990) 177-188
43. Drouot X., Oshino S., Jarraya B., Besret L., Kishima H., Remy P., Dauguet J., Lefaucheur J.P., Dolle F., Conde F., Bottlaender M., Peschanski M., Keravel Y., Hantraye P., and Palfi S. Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation. Neuron 44 (2004) 769-778
44. Eberling J.L., Jagust W.J., Taylor S., Bringas J., Pivirotto P., VanBrocklin H.F., and Bankiewicz K.S. A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes. Brain Research 805 (1998) 259-262
45. Elsworth J.D., Taylor J.R., Sladek Jr. J., Collier T.J., Redmond D.E.J., and Roth R.H. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neuroscience 95 (2000) 399-408
46. Filion M., and Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Research 547 (1991) 142-151
47. Fiorillo C.D., Tobler P.N., and Schultz W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science 299 (2003) 1898-1902
48. Garcia L., Audin J., D'Alessandro G., Bioulac B., and Hammond C. Dual effect of high-frequency stimulation on subthalamic neuron activity. The Journal of Neuroscience 23 (2003) 8743-8751
49. Garcia L., D'Alessandro G., Bioulac B., and Hammond C. High-frequency stimulation in Parkinson's disease: more or less?. Trends in Neuroscience 28 (2005) 209-216
50. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma Jr. F.J., and Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250 (1990) 1429-1432
51. Gill S.S., and Heywood P. Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease. The Lancet 350 (1997) 1224
52. Gillies A., and Arbuthnott G. Computational models of the basal ganglia. Movement Disorders 15 (2000) 762-770
53. Goldberg J.A., Boraud T., Maraton S., Haber S.N., Vaadia E., and Bergman H. Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease. Journal of Neuroscience 22 (2002) 4639-4653
54. Graham W.C., Robertson R.G., Sambrook M.A., and Crossman A.R. Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism. Life Science 47 (1990) PL91-PL97
55. Graybiel A.M., Aosaki T., Flaherty A.W., and Kimura M. The basal ganglia and adaptive motor control. Science 265 (1994) 1826-1831
56. Gross Ch., Feger J., Seal J., Haramburu Ph., and Bioulac B. Neuronal activity in area 4 and movement parameters recorded in trained monkeys after unilateral lesion of the substantia nigra. Experimental Brain Research Supplement 7 (1983) 181-193
57. Gross C.E., Boraud T., Guehl D., Bioulac B., and Bezard E. From experimentation to the surgical treatment of Parkinson's disease: prelude or suite in basal ganglia research?. Progress in Neurobiology 59 (1999) 509-532
58. Guridi, J., Luguin, M.R., Herrero, M.T., Guillen, J., Obeso, J.A., 1993. Antiparkinsonian Effect of Subthalmotomy in MPTP-Exposed Monkeys, p. 415.
59. Guridi J., Herrero M.T., Luquin M.R., Guillen J., Ruberg M., Laguna J., Vila M., Javoy A.F., Agid Y., Hirsch E., and Obeso J.A. Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis. Brain 119 (1996) 1717-1727
60. Gurney K., Prescott T.J., Wickens J.R., and Redgrave P. Computational models of the basal ganglia: from robots to membranes. Trends in Neuroscience 27 (2004) 453-459
61. Hantraye P., Varastet M., Peschanski M., Riche D., Cesaro P., Willer J.C., and Maziere M. Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons. Neuroscience 53 (1993) 169-178
62. Hashimoto T., Elder C.M., Okun M.S., Patrick S.K., and Vitek J.L. Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. The Journal of Neuroscience 23 (2003) 1916-1923
63. Hayase N., Filion M., Richard H., and Boraud T. Electrical stimulation of the subthalamic nucleus in fully parkinsonian (MPTP) monkeys: effect on clinical signs and pallidal activity. In: Ohye C., Kimura M., and McKenzie J.S. (Eds). The Basal Ganglia V (1996), Plenum Press 241-248
64. Hazrati L.N., Parent A., Mitchell S., and Haber S.N. Evidence for interconnections between the two segments of the globus pallidus in primates: a PHA-L anterograde tracing study. Brain Research 533 (1990) 171-175
65. Heimer G., Bar-Gad I., Goldberg J.A., and Bergman H. Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism. Journal of Neuroscience 22 (2002) 7850-7855
66. Hurtado J.M., Gray C.M., Tamas L.B., and Sigvardt K.A. Dynamics of tremor-related oscillations in the human globus pallidus: a single case study. Proceedings of the National Academy of Science of the United States America 96 (1999) 1674-1679
67. Jaeger D., Kita H., and Wilson C.J. Surround inhibition among projection neurons is weak or nonexistent in the rat neostriatum. Journal of Neurophysiology 72 (1994) 2555-2558
68. Jenkinson N., Nandi D., Aziz T.Z., and Stein J.F. Pedunculopontine nucleus: a new target for deep brain stimulation for akinesia. Neuroreport 16 (2005) 1875-1876
69. Jenner P., Rose S., Nomoto M., and Marsden C.D. MPTP-induced parkinsonism in the common marmoset: behavioral and biochemical effects. In: Yahr M.D., and Bergmann K.J. (Eds). Parkinson's Disease (1986), Raven, New York 183-186
70. Jog M.S., Kubota Y., Connolly C.I., Hillegaart V., and Graybiel A.M. Building neural representations of habits. Science 286 (1999) 1745-1749
71. Johnson S.W., Palmer M.R., and Freedman R. Effects of dopamine on spontaneous and evoked activity of caudate neurons. Neuropharmacology 22 (1983) 843-851
72. Kase H., et al. Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease. Neurology 61 (2003) S97-S100
73. Kawagoe R., Takikawa Y., and Hikosaka O. Expectation of reward modulates cognitive signals in the basal ganglia. Nature Neuroscience 1 (1998) 411-416
74. Kawaguchi Y., Wilson C.J., and Emson P.C. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. The Journal of Neuroscience 10 10 (1990) 3421-3438
75. Kawaguchi Y., Wilson C.J., Augood S.J., and Emson P.C. Striatal interneurons: chemical, physiological and morphological characterization. TINS 18 (1995) 527-535
76. Kish S.J., Shannak K., and Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. New England Journal of Medicine 318 (1988) 876-880
77. Kiyatkin E.A., and Rebec G.V. Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats. Journal of Neurophysiology 75 (1996) 142-153
78. Krack P., Batir A., Van Blercom N., Chabardes S., Fraix V., Ardouin C., Koudsie A., Limousin P.D., Benazzouz A., Lebas J.F., Benabid A.L., and Pollak P. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. New England Journal of Medicine 349 (2003) 1925-1934
79. Kumar R., Lozano A.M., Montgomery E., and Lang A.E. Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease. Movement Disorders 13 Suppl. 1 (1998) 73-82
80. Laitinen L.V., Bergenheim A.T., and Hariz M.I. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. Journal of Neurosurgery 76 (1992) 53
81. Lang A.E., and Lozano A.M. Parkinson's disease. Second of two parts. New England Journal of Medicine 339 (1998) 1130-1143
82. Lang A.E., Lozano A.M., Montgomery E., Duff J., Tasker R., and Hutchinson W. Posteroventral medial pallidotomy in advanced Parkinson's disease. New England Journal of Medicine 337 (1997) 1036-1042
83. Langston J.W., Ballard P., Tetrud J.W., and Irwin I. Chronic Parkinsonism in humans due to a product of meperidine- analog synthesis. Science 219 (1983) 979-980
84. Langston J.W., Irwin I., and Langston E.B. A comparison of the acute and chronic effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-induced parkinsonism in humans and the squirrel monkey. Neurology 34 Suppl. 1 (1984) 268
85. Lefaucheur J.P., Drouot X., Von R.F., Menard-Lefaucheur I., Cesaro P., and Nguyen J.P. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease. Clinical Neurophysiology 115 (2004) 2530-2541
86. Levesque M., and Parent A. The striatofugal fiber system in primates: a reevaluation of its organization based on single-axon tracing studies. Proceedings of the National Academy of Science of United States of America 102 (2005) 11888-11893
87. Levy R., Hazrati L.N., Herrero M.T., Vila M., Hassani O.K., Mouroux M., Ruberg M., ASENSI H., Agid Y., Feger J., Obeso J.A., Parent A., and Hirsch E.C. Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states. Neuroscience 76 (1997) 335-343
88. Levy R., Hutchison W.D., Lozano A.M., and Dostrovsky J.O. High-frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor. Journal of Neuroscience 20 (2000) 7766-7775
89. Limousin P., Pollak P., Benazzouz A., Hoffmann D., Broussolle E., Perret J.E., and Benabid A.L. Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Movement Disorders 10 (1995) 672-674
90. Limousin-Dowsey P., Pollak P., Van B.N., Krack P., Benazzouz A., and Benabid A. Thalamic, subthalamic nucleus and internal pallidum stimulation in Parkinson's disease. Journal of Neurology 246 Suppl. 2 (1999) II42-II45
91. Llinas R.R. The intrinsic electrophysiological properties of mammalian neurons: insights into central nervous system function. Science 242 (1988) 1654-1664
92. Lozano A.M., and Eltahawy H. How does DBS work?. Supplement to Clinical Neurophysiology 57 (2004) 733-736
93. Lozano A.M., Lang A.E., Galvez Jimenez N., Miyasaki J., Duff J., Hutchinson W.D., and Dostrovsky J.O. Effect of GPi pallidotomy on motor function in Parkinson's disease. The Lancet 346 (1995) 1383-1387
94. Marsden C.D., and Obeso J.A. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 117 (1994) 877-897
95. Matsumoto N., Hanakawa T., Maki S., Graybiel A.M., and Kimura M. Nigrostriatal dopamine system in learning to perform sequential motor tasks in a predictive manner. Journal of Neurophysiology 82 (1999) 978-998
96. Miller W.C., and DeLong M.R. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. In: Carpenter M.B., and Jayaraman A. (Eds). The Basal Ganglia II (1987), Plenum Press, New York 415-427
97. Mink J.W. The basal ganglia: focused selection and inhibition of competing motor programs. Progress in Neurobiology 50 (1996) 381-425
98. Mori A., and Shindou T. Modulation of GABAergic transmission in the striatopallidal system by adenosine A2A receptors: a potential mechanism for the antiparkinsonian effects of A2A antagonists. Neurology 61 (2003) S44-S48
99. Morris G., Arkadir D., Nevet A., Vaadia E., and Bergman H. Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons. Neuron 43 (2004) 133-143
100. Nambu A. A new dynamic model of the cortico-basal ganglia loop. Progress in Brain Research 143 (2004) 461-466
101. Nicola S.M., Surmeier J., and Malenka R.C. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annual Review of Neuroscience 23 (2000) 185-215
102. Nini A., Feingold A., Slovin H., and Bergman H. Neurons in the globus pallidus do not show correlated activity in the normal monkey, but phase-locked oscillations appear in the MPTP model of parkinsonism. Journal of Neurophysiology 74 (1995) 1800-1805
103. Obeso J.A., Alvarez L.M., Macias R.J., Guridi J., Teijeiro J., Juncos J.L., Rodriguez M.C., Ramos E., Linazasoro G.J., Gorospe A., and DeLong M.R. Lesion of the subthalamic nucleus is Parkinson's disease. Neurology 48 (1997) A138
104. Pahapill P.A., and Lozano A.M. The pedunculopontine nucleus and Parkinson's disease. Brain 123 (2000) 1767-1783
105. Pare D., Curro'Dossi R., and Steriade M. Neuronal basis of the parkinsonian resting tremor: a hypothesis and its implications for treatment. Neuroscience 35 (1990) 217-226
106. Parent A., and Hazrati L.N. Anatomical aspects of information processing in primate basal ganglia. Trends in Neuroscience 16 (1993) 111-116
107. Parent A., Sato F., Wu Y., Gauthier J., Levesque M., and Parent M. Organization of the basal ganglia: the importance of axonal collateralization. Trends in Neuroscience 23 (2000) S20-S27
108. Perez Otano I., Oset C., Luquin M.R., Herrero M.T., Obeso J.A., and Del Rio J. Mptp-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration. Neuroscience Letters 175 (1994) 121-125
109. Pessiglione M., Guehl D., Rolland A.S., Francois C., Hirsch E.C., Feger J., and Tremblay L. Thalamic neuronal activity in dopamine-depleted primates: evidence for a loss of functional segregation within basal ganglia circuits. The Journal of Neuroscience 25 (2005) 1523-1531
110. Pifl C., Schingnitz G., and Hornykiewicz O. The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease. Neuroscience Letters 92 (1988) 228-233
111. Pifl C., Schingnitz G., and Hornykiewicz O. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Neuroscience 44 (1991) 591-605
112. Pollak P., Benabid A.L., Limousin P., Benazzouz A., Hoffmann D., Le Bas J.F., and Perret J. Subthalamic nucleus stimulation alleviates akinesia and rigidity in parkinsonian patients. Advances in Neurology 69 (1996) 591-594
113. Ranck J.B. Which elements are excited in electrical stimulation of mammalian central nervous system: a review. Brain Research 98 (1975) 417-440
114. Raz A., Feingold A., Zelanskaya V., Vaadia E., and Bergman H. Neuronal synchronization of tonically active neurons in the striatum of normal and parkinsonian primates. Journal of Neurophysiology 76 (1996) 2083-2088
115. Raz A., Vaadia E., and Bergman H. Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. The Journal of Neuroscience 20 (2000) 8559-8571
116. Raz A., Frechter-Mazar V., Feingold A., Abeles M., Vaadia E., and Bergman H. Activity of pallidal and striatal tonically active neurons is correlated in MPTP-treated monkeys but not in normal monkeys. The Journal of Neuroscience 21 RC128 (2001) 1-5
117. Redmond, D.E., Roth, R.H., Sladek, J.R., 1985. MPTP Produces Classic Parkinsonian Syndrome in African Green Monkeys, p. 166.
118. Roeltgen D.P., and Schneider J.S. Task persistence and learning ability in normal and chronic low dose MPTP-treated monkeys. Behavioural Brain Research 60 (1994) 115-124
119. Rothblat D.S., and Schneider J.S. Response of caudate neurons to stimulation of intrinsic and peripheral afferents in normal, symptomatic, and recovered MPTP-treated cats. The Journal of Neuroscience 13 (1993) 4372-4378
120. Samejima K., Ueda Y., Doya K., and Kimura M. Representation of action-specific reward values in the striatum. Science 310 (2005) 1337-1340
121. Schneider J.S. Chronic exposure to low doses of MPTP. II. Neurochemical and pathological consequences in cognitively-impaired, motor asymptomatic monkeys. Brain Research 534 (1990) 25-36
122. Schneider J.S., and Kovelowski II C.J. Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys. Brain Research 519 (1990) 122-128
123. Schneider J.S., and Pope Coleman A. Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey. Neurodegeneration 4 (1995) 245-255
124. Schneider J.S., and Roeltgen D.P. Delayed matching-to-sample, object retrieval, and discrimination reverasl deficits in chronic low dose MPTP treated monkeys. Brain Research 615 (1993) 351-354
125. Schultz W. Predictive reward signal of dopamine neurons. Journal of Neurophysiology 80 (1998) 1-27
126. Schultz W., Studer A., Jonsson G., Sundstrom E., and Mefford I. Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism. Neuroscience Letters 59 (1985) 225-232
127. Schultz W., Romo R., Scarnati E., Sundstrom E., Jonsson G., and Studer A. Saccadic reaction times, eye-arm coordination and spontaneous eye movements in normal and MPTP-treated monkeys. Experimental Brain Research 78 (1989) 253-267
128. Schultz W., Studer A., Romo R., Sundstrom E., Jonsson G., and Scarnati E. Deficits in reaction times and movement times as correlates of hypokinesia in monkeys with MPTP-induced striatal dopamine depletion. Journal of Neurophysiology 61 (1989) 651-668
129. Schultz W., Tremblay L., and Hollerman J.R. Changes in behavior-related neuronal activity in the striatum during learning. Trends in Neuroscience 26 (2003) 321-328
130. Seung H.S., and Lee D.D. The manifold ways of perception. Science 290 (2001) 2268-2269
131. Slovin H., Abeles M., Vaadia E., Haalman I., Prut Y., and Bergman H. Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys. Journal of Neurophysiology 81 (1999) 858-874
132. Smith Y., Bevan M.D., Shink E., and Bolam J.P. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86 (1998) 353-387
133. Song D.D., and Haber S.N. Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting. Journal of Neuroscience 20 (2000) 5102-5114
134. Stern Y., and Langston J.W. Intellectual changes in patients with MPTP-induced parkinsonism. Neurology 35 (1985) 1506-1509
135. Stern Y., Tetrud J.W., Martin W.R., Kutner S.J., and Langston J.W. Cognitive change following MPTP exposure. Neurology 40 (1990) 261-264
136. Stoney Jr. S.D., Thompson W.D., and Asanuma H. Excitation of pyramidal tract cells by intracortical microstimulation: effective treatment of stimulating current. Journal of Neurophysiology 31 (1968) 659-669
137. Surmeier D.J., Reiner A., Levine M.S., and Ariano M.A. Are neostriatal dopamine receptors co-localized? [see comments]. Trends in Neuroscience 16 (1993) 299-305
138. Surmeier D.J., Song W.J., and Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. Journal of Neuroscience 16 (1996) 6579-6591
139. Tass P.A. Phase Resetting in Medicine and Biology (1999), Springer, Berlin
140. Toan D.L., and Schultz W. Responses of rat pallidum cells to cortex stimulation and effects of altered dopaminergic activity. Neuroscience 15 (1985) 683-694
141. Tseng K.Y., Kasanetz F., Kargieman L., Riquelme L.A., and Murer G. Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions. The Journal of Neuroscience 21 (2001) 6430-6439
142. Turner R.S., and Anderson M.E. Pallidal discharge related to the kinematics of reaching movements in two dimensions. Journal of Neurophysiology 77 (1997) 1051-1074
143. Vitek J.L., and Bakay R.A. The role of pallidotomy in Parkinson's disease and dystonia. Current Opinion on Neurology 10 (1997) 332-339
144. Watts R.L., and Mandir A.S. The role of motor cortex in the pathophysiology of voluntary movement deficits associated with parkinsonism. Neurological Clinics 10 (1992) 451-469
145. Wichmann T., and DeLong M.R. Functional and pathophysiological models of the basal ganglia. Current Opinion on Neurobiology 6 (1996) 751-758
146. Wichmann T., Bergman H., and DeLong M.R. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. Journal of Neurophysiology 72 (1994) 521-530
147. Wichmann T., Bergman H., Starr P.A., Subramanian T., Watts R.L., and DeLong M.R. Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates. Experimental Brain Research 125 (1999) 397-409
148. Wilms H., Sievers J., and Deuschl G. Animal models of tremor. Movement Disorders 14 (1999) 557-571
149. Wilson C.J. The generation of natural firing patterns in neostriatal neurons. Progress in Brain Research 99 (1993) 277-297
150. Wilson C.J. The Basal Ganglia. In: Shepherd G.M. (Ed). The Synaptic Organization of the Brain (2003), Oxford University Press, Oxford
151. Yoshida M. The neuronal mechanism underlying parkinsonism and dyskinesia: differential roles of the putamen and caudate nucleus. Journal of Neuroscience Research 12 (1991) 31-40